Abstract:Biniam Endale Geleta, Girma Seyoum Department of Anatomy, Addis Ababa University, Addis Ababa, Ethiopia Correspondence: Biniam Endale Geleta, Email Background: Children with DS are at higher risk of developing congenital anomalies, particularly cardiac anomalies. Methods: Medical records of 502 DS patients were reviewed. The logistic regression analyses were performed to determine independent predictors. Results: Of the total 502 study subjects, 53.4% were males. Only 1.4% of the DS case diagnosis were confirmed by karyotyping. All cases were diagnosed postnatally. The median age at DS diagnosis was 5 months. About 13% were born preterm; 50.2% of the subjects maternal age at conception were thirty-five years and above. Over three-quarters (75.1%) had at least one structural congenital anomaly. Multiple anomalies were diagnosed in 12.8% of the subjects. At least one cardiac congenital anomaly was diagnosed in 67.3% of the study subjects, and 32.8% of them were diagnosed with multiple cardiac anomalies. Patent ductus arteriosus (28.5%), Ventricular septal defect (23.2%), and AVSD (21.9%) were the three common lesions. At least one genitourinary system anomaly was identified in 32 (6.4%) of them. Roughly, 8% of study participants exhibited congenital anomaly of the head, eye, nose, and throat. Anorectal malformation was found as the most common gastrointestinal anomaly. Maternal age at conception was found as independent predictor for presence of structural congenital anomaly (AOR 2.59; 95% CI 1.58– 4.23, p-value < 0.01). Advanced maternal age is also found increasing the risk of developing congenital heart defect (AOR 2.37; 95% CI 1.52– 3.7, p-value < 0.01). Conclusion: High prevalence of congenital anomalies has been noted in the current study compared to previous studies. Predictive factors increasing risk of congenital anomalies in DS patients have been identified. The current findings may help in developing strategies and more targeted preventive and therapeutic interventions. Keywords: Down syndrome, congenital anomaly, cardiac anomaly, maternal age, chromosome 21 Down syndrome (DS) is a chromosomal abnormality characterized by the presence of an extra copy of human chromosome 21. 1 It is the most prevalent chromosomal abnormality that allows for survival beyond the embryonic stage; affecting 1 per 700 to 1000 live births globally. 2–4 The incidence of Down syndrome (DS) is decreasing in developed countries due to widespread prenatal testing and elective termination of affected pregnancies. 5 In contrast, limited access to antenatal care in Africa and other developing countries poses a significant challenge for prenatal DS diagnosis, leading to late diagnoses after birth. 1,6 While karyotyping remains the gold standard for DS diagnosis, its accessibility and affordability are significant barriers in developing countries like Ethiopia. Therefore, clinical diagnosis based on physical features and behavior is commonly employed in these settings, including the one in which this study was conducted. 6–8 However, these clinical diagnostic standards were primarily developed in high-income countries and may not be as accurate in LMICs due to potential phenotypic variations across regions and ethnicities. 1,8,9 Additionally, studies have shown that the accuracy of clinical diagnosis varies significantly between DS subtypes. One study reported overdiagnosis in up to one-third of cases, while another found accuracy rates of 90% for free trisomy, 100% for translocation, and only 37.5% for mosaicism. 9,10 Congenital anomalies are more common among DS patients than the general population. This is attributed to a combination of gene dosage imbalance and epigenetic factors. However, the pattern and prevalence of these anomalies vary from one region to the other. 11 Stoll et al reported 64% prevalence of congenital anomalies in children with DS. While the Egyptian study reported 59.9% prevalence among infants. 12 Chance of development of these anomalies was found increased by factors like advanced maternal age, paternal age, gestational age, and birth weight. 13 Cardiac lesions are the most common congenital anomalies among children with DS. About half of patients with DS have at least one form of cardiac anomaly. 12,14 Variations are noted among regions. Accordingly, a study of twenty European countries reported prevalence of 43.6%. Other studies from Urban and rural areas of France and Guatemala reported 44% and 54%, respectively. 14,15 While the study from Sub-Saharan Sudan found 91% prevalence among clinically diagnosed children undergone echocardiographic examination. 16 Gender variation was note -Abstract Truncated-

Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes

Human Chromosome 21 Orthologous Region on Mouse Chromosome 17 is a Major Determinant of Down Syndrome-Related Developmental Cognitive Deficits.

Erratum: Genetic analysis of Down syndrome-associated heart defects in mice (Human Genetics DOI: 10.1007/s00439-011-0980-2)

Genome-wide association studies of Down syndrome associated congenital heart defects

Genetic analysis of Down syndrome-associated heart defects in mice

Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling

Genome-wide expression analysis in Down syndrome: insight into immunodeficiency

Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome

Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients

Prevalence and Patterns of Congenital Heart Defects and Other Major Non-Syndromic Congenital Anomalies Among Down Syndrome Patients: A Retrospective Study

Computational analysis of congenital heart disease associated SNPs: Unveiling their impact on the gene regulatory system

VEGF C|[minus]|634G polymorphism is associated with protection from isolated ventricular septal defect: case|[ndash]|control and TDT studies

VEGF C−634G Polymorphism is Associated with Protection from Isolated Ventricular Septal Defect: Case–control and TDT Studies

Competing Endogenous RNAs Crosstalk in Hippocampus: A Potential Mechanism for Neuronal Developing Defects in Down Syndrome

Association of Maternal Diabetes Mellitus and Polymorphisms of the NKX2.5 Gene in Children with Congenital Heart Disease: A Single Centre-Based Case-Control Study

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease

DNAH11 Variants and Its Association with Congenital Heart Disease and Heterotaxy Syndrome

Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS

Association of Genetic Polymorphisms of De Novo Nucleotide Biosynthesis with Increased Chd Susceptibility in the Northern Chinese Population

Phenotyping Down syndrome: discovery and predictive modelling with electronic medical records

DYRK1A gene linked to heart defects in Down syndrome